Biocon targets emerging, developed markets with biosimilars
Advertisement
NEW DELHI: Biopharmaceuticals firm Biocon is looking to tap opportunities in biosimilars targeting diseases such as diabetes and cancer among others, in both emerging and developed markets.
The company expects regulatory filings in the US and Europe by 2016-17 for some of its biosimilars out of the five development programmes that it is currently undertaking with pharma firm Mylan.
Biosimilars are types of biological products that are used for treatment of various diseases.
"Biocon aims to provide high quality biosimilars to patients across the world, both in emerging and developed markets," Biocon Chairperson and Managing Director Kiran Mazumdar-Shaw told PTI.
Giving an update on the progress of the company's biosimilars programmes, she said: "The clinical development of five biosimilars programmes in partnership with Mylan is progressing well."
The clinical advancement of these programmes has put the company on track for regulatory filings for some of these in the US and Europe in FY17, she added.
The company expects regulatory filings in the US and Europe by 2016-17 for some of its biosimilars out of the five development programmes that it is currently undertaking with pharma firm Mylan.
Biosimilars are types of biological products that are used for treatment of various diseases.
"Biocon aims to provide high quality biosimilars to patients across the world, both in emerging and developed markets," Biocon Chairperson and Managing Director Kiran Mazumdar-Shaw told PTI.
Giving an update on the progress of the company's biosimilars programmes, she said: "The clinical development of five biosimilars programmes in partnership with Mylan is progressing well."
The clinical advancement of these programmes has put the company on track for regulatory filings for some of these in the US and Europe in FY17, she added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.